Chemical Biology News

  • Honorary appointment at the University of Birmingham

    CBV's founder Lloyd Czaplewski has been appointed as an Honorary Senior Research Fellow in the School of Immunity & Infection within the College of Medical & Dental Sciences at the University of Birmingham, U.K.

    Recently Dr Czaplewski located his antibacterial company, Abgentis Limited, the antibiotic re-engineering Company, at the University of Birmingham Research Park. This Honorary position will provide exciting opportunities to develop collaborative projects that build on the excellent platforms developed by Abgentis and on Birmingham's world-leading research and increasingly translational focus on microbiology and infection.


Chemical Biology Ventures News

Welcome to Chemical Biology Ventures News

CBV updates & relevant chemical biology papers, news & comments will be posted

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.

Get Flash Player